Related Experiment Video

Updated: Jul 2, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

HIV and hepatitis C coinfection

Gail V Matthews1, Gregory J Dore

  • 1Viral Hepatitis Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia. gmatthews@nchecr.unsw.edu.au

Journal of Gastroenterology and Hepatology
|August 19, 2008
PubMed

Insights

HIV/hepatitis C virus (HCV) coinfection poses significant health risks, including accelerated liver disease and treatment complications. Early diagnosis and tailored treatment strategies are crucial for managing coinfected individuals, with new therapies on the horizon.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • HIV/HCV coinfection presents a substantial global health burden, particularly in the Asia-Pacific region.
  • Coinfected individuals face accelerated liver disease progression, leading to cirrhosis, liver failure, and hepatocellular carcinoma.
  • Altered immune responses and increased risk of hepatotoxicity from highly active antiretroviral therapy (HAART) are concerns in coinfected patients.

Purpose of the Study:

  • To review the challenges and current management strategies for HIV/HCV coinfection.
  • To emphasize the importance of early diagnosis and treatment assessment for HCV in coinfected individuals.
  • To discuss the implications of coinfection on treatment outcomes and the potential of novel therapies.

Main Methods:

  • Review of current literature on HIV/HCV coinfection management.
  • Analysis of treatment outcomes with standard pegylated interferon and ribavirin therapy.
  • Discussion of factors influencing treatment response and toxicity.

Main Results:

  • HCV treatment response rates in coinfected individuals are 10-15% lower than in HCV monoinfection.
  • Drug interactions and toxicity complicate HCV treatment in coinfected patients.
  • Baseline factors and on-treatment monitoring aid in predicting and individualizing therapy.

Conclusions:

  • HCV treatment is often recommended before initiating HAART to mitigate drug interactions and hepatotoxicity.
  • Early diagnosis of both HIV and HCV is essential for effective management.
  • Emerging therapies like protease and polymerase inhibitors offer future treatment possibilities for HIV/HCV coinfected individuals.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...